Cyclopharm Yönetim

Yönetim kriter kontrolleri 1/4

Cyclopharm CEO'su James McBrayer, Jun2008 tarihinde atandı, in görev süresi 16.42 yıldır. in toplam yıllık tazminatı A$ 893.46K olup, şirket hissesi ve opsiyonları dahil olmak üzere 52.7% maaş ve 47.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 4.78% ine doğrudan sahiptir ve bu hisseler A$ 7.33M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.5 yıl ve 2.7 yıldır.

Anahtar bilgiler

James McBrayer

İcra Kurulu Başkanı

AU$893.5k

Toplam tazminat

CEO maaş yüzdesi52.7%
CEO görev süresi16.4yrs
CEO sahipliği4.8%
Yönetim ortalama görev süresi6.5yrs
Yönetim Kurulu ortalama görev süresi2.7yrs

Son yönetim güncellemeleri

Recent updates

What You Can Learn From Cyclopharm Limited's (ASX:CYC) P/SAfter Its 26% Share Price Crash

Oct 28
What You Can Learn From Cyclopharm Limited's (ASX:CYC) P/SAfter Its 26% Share Price Crash

Is Cyclopharm Limited (ASX:CYC) Trading At A 25% Discount?

Apr 18
Is Cyclopharm Limited (ASX:CYC) Trading At A 25% Discount?

Companies Like Cyclopharm (ASX:CYC) Are In A Position To Invest In Growth

Mar 31
Companies Like Cyclopharm (ASX:CYC) Are In A Position To Invest In Growth

Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Oct 17
Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Jun 09
Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher

Mar 06
Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher

Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation

Mar 02
Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation

We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth

Oct 22
We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth

Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates

Jun 29
Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates

Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being

Apr 27
Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being

Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic

Mar 01
Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic

Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment

Feb 07
Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment

Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?

Jan 02
Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?

We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate

Dec 06
We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate

CEO Tazminat Analizi

James McBrayer'un ücretlendirmesi Cyclopharm'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-AU$9m

Mar 31 2024n/an/a

-AU$7m

Dec 31 2023AU$893kAU$471k

-AU$5m

Sep 30 2023n/an/a

-AU$6m

Jun 30 2023n/an/a

-AU$7m

Mar 31 2023n/an/a

-AU$7m

Dec 31 2022AU$850kAU$439k

-AU$7m

Sep 30 2022n/an/a

-AU$5m

Jun 30 2022n/an/a

-AU$4m

Mar 31 2022n/an/a

-AU$4m

Dec 31 2021AU$957kAU$427k

-AU$5m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021n/an/a

-AU$4m

Mar 31 2021n/an/a

-AU$5m

Dec 31 2020AU$1mAU$406k

-AU$6m

Sep 30 2020n/an/a

-AU$6m

Jun 30 2020n/an/a

-AU$6m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019AU$753kAU$341k

-AU$3m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019n/an/a

-AU$2m

Mar 31 2019n/an/a

-AU$1m

Dec 31 2018AU$426kAU$335k

-AU$35k

Sep 30 2018n/an/a

-AU$409k

Jun 30 2018n/an/a

-AU$782k

Mar 31 2018n/an/a

-AU$1m

Dec 31 2017AU$421kAU$327k

-AU$2m

Tazminat ve Piyasa: James 'nin toplam tazminatı ($USD 580.62K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 297.98K ).

Tazminat ve Kazançlar: James şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

James McBrayer (59 yo)

16.4yrs

Görev süresi

AU$893,462

Tazminat

Mr. James S. McBrayer, BSPharm, GDM, FAICD, AIM, has been the Managing Director at Cyclopharm Ltd. since June 3, 2008 and also serves as its Chief Executive Officer. Mr. McBrayer has been Company Secretary...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
James McBrayer
CEO, MD16.4yrsAU$893.46k4.78%
A$ 7.3m
Mathew Farag
Chief Operating Officer7.8yrsAU$484.33k0.45%
A$ 690.0k
Graham Phillips
Finance Managerno dataAU$152.73kVeri yok
Sally-Ann Cornelius
Head of Sales5.2yrsVeri yokVeri yok
Niamh McAree
Head of Quality and Regulatory5.2yrsVeri yokVeri yok
Chris Quinn
Head of Service5.2yrsVeri yokVeri yok
Sui Cheah
Financial Controller13.7yrsAU$64.44kVeri yok
Lynn McLauchlin
General Manager of Canadano dataAU$173.42kVeri yok
Gary Somerville
Quality & Regulatory Managerno dataAU$151.96kVeri yok

6.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim: CYC 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
James McBrayer
CEO, MD16.4yrsAU$893.46k4.78%
A$ 7.3m
Dianne Angus
Independent Non-Executive Director3.3yrsAU$60.76k0.020%
A$ 30.8k
David Heaney
Independent Non-Executive Chairman18yrsAU$85.07k0.27%
A$ 415.6k
John Wigglesworth
Non-Executive Directorless than a yearVeri yok0.049%
A$ 74.5k
Kevin M. Barrow
Independent Non-Executive Director2.2yrsAU$60.76k0.023%
A$ 34.6k
Gregory King
Independent Non-Executive Director2.2yrsAU$60.76k0.0090%
A$ 13.8k

2.7yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CYC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.7 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.